CLIA Kit for Docosahexaenoic Acid (DHA)

Doconexent; Cervonic Acid

Specificity

This assay has high sensitivity and excellent specificity for detection of Docosahexaenoic Acid (DHA).
No significant cross-reactivity or interference between Docosahexaenoic Acid (DHA) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of Docosahexaenoic Acid (DHA) and the recovery rates were calculated by comparing the measured value to the expected amount of Docosahexaenoic Acid (DHA) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-104 88
EDTA plasma(n=5) 92-104 97
heparin plasma(n=5) 85-101 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Docosahexaenoic Acid (DHA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Docosahexaenoic Acid (DHA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Docosahexaenoic Acid (DHA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-105% 78-97% 80-103% 93-102%
EDTA plasma(n=5) 82-95% 80-97% 92-99% 78-104%
heparin plasma(n=5) 78-97% 85-92% 93-101% 88-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Iranian Journal of Kidney Diseases Clinical Characterization of Serum Docosahexaenoic Acid and Its Relationship With Inflammation Factors in Patients With Diabetic Nephropathy Pubmed:29507271
Journal of Experimental & Clinical Cancer Research MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2 Pubmed: 31856871
J Agric Food Chem Novel Nanoliposome Codelivered DHA and Anthocyanidin: Characterization, In Vitro Infant Digestibility, and Improved Cell Uptake 34344151
Catalog No. Related products for research use of Pan-species (General) Organism species Applications (RESEARCH USE ONLY!)
CPO623Ge11 BSA Conjugated Docosahexaenoic Acid (DHA) Immunogen; SDS-PAGE; WB.
CPO623Ge21 OVA Conjugated Docosahexaenoic Acid (DHA) Immunogen; SDS-PAGE; WB.
PAO623Ge01 Polyclonal Antibody to Docosahexaenoic Acid (DHA) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
CEO623Ge ELISA Kit for Docosahexaenoic Acid (DHA) Enzyme-linked immunosorbent assay for Antigen Detection.
CCO623Ge CLIA Kit for Docosahexaenoic Acid (DHA) Chemiluminescent immunoassay for Antigen Detection.
LMO623Ge Multiplex Assay Kit for Docosahexaenoic Acid (DHA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.